9TH Annual CMOD United States Biomarkers Symposium
and Surrogate Endpoints Meeting

Robert Temple, US FDA
Peter Libby, Brigham and Women’s Hospital
Agnes Klein, Health Canada
Steven Bauer, OCTGT/CBER, FDA
Pat O’Mahony, European Medicines Agency
Suzanne Bracken, Molecular Medicine Ireland
Robert Balaban, NHLBI, NIH
Simhan Danthi, NHLBI, NIH
Peter Liu, University of Toronto
Doris Taylor, University of Minnesota
Lance Liotta, George Mason University
Jean-Claude Tardif, Montreal Heart Institute
Allen J. Taylor, Georgetown University
Marc Walton, US FDA
Melanie Blank, US FDA
Andrew Levey, Tufts Med Center
Robert Fiorentino, US FDA
Issam Zineh, US FDA
Douglas Throckmorton, US FDA
Alan Remaley, NHLBI, NIH
Bryan Brewer, Medstar Research
Yves Rosenberg, NHLBI, NIH
Robert Rosenson, Mt. Sinai Medical Center